1. Inhibition of DNA methylation by 5-azacytidine;Jones;Recent Results Cancer Res,1983
2. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias;Leone;Haematologica,2002
3. Inhibitors of DNA methylation in the treatment of haematological malignancies and MDS;Leone;Clin Immunol,2003
4. Celgene Corporation. Highlights of Vidaza (azacitidine for injection) prescribing information. www.vidaza.com/pdf/PI_FINAL.pdf (accessed 2012 Aug 9).
5. European Medicines Agency. Summary of product characteristics: azacitidine. www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000978/WC500050239.pdf (accessed 2012 Jun 20).